Clinical efficacy of Darvoni as a generic medicine

Use of generic medicines has been increasing in recent years, primarily as a cost saving measure in healthcare provision. Generic medicines are typically 20 to 90% cheaper than originator equivalents. BEACON’s objective is to provide quality generic medicines at an...

Darvoni Spread BEACON’s footprint in USA !!!!

A Patient from USA is going to start Darvoni from today in order to fight against Hepatitis C. This is huge breakthrough of BEACON’s global operation which brings a new arena in Pharmaceuticals Business at Bangladesh. The Delivery report has been attached to...

Memorandum of Understanding

Beacon Pharmaceuticals and Hepatitis Hilfe Belgrade has signed a memorandum of Understanding with an objective to give an adequate response to global pandemic of viral hepatitis C.